We were pleased to have our team present two scientific posters on our preclinical research supporting a MagSense® imaging agent for the detection of ovarian cancer at the Annual Association of Cancer Research (AACR) meeting held in Orlando, Florida April 14-19, 2023- see below for poster details.
Ovarian Cancer is often referred to as the “silent killer” because it is largely asymptomatic until late stage and conventional imaging methods are not sensitive enough to detect early and smaller tumors, with only 20-25% of ovarian cancers diagnosed in early stages. However, when ovarian cancer is detected at an early stage (I or II), cytoreductive surgery and conventional chemotherapy can cure 70-90% of patients, compared with approximately 20% of those patients diagnosed at late stage (III and IV).
Reliable detection of ovarian cancer at an earlier stage should significantly improve the type and range of treatment options available to women afflicted with ovarian cancer. We are developing the MagSense® Ovarian Cancer imaging agent with this in mind.
Poster info is below. You may request copies by filling out the form.
Download our AACR 2023 Posters
You'll have immediate access to download.
Presented 2023 AACR posters
.png?width=475&height=325&name=AACR%202023_3590%20poster%20thumb_475x350%20(2).png "AACR 2023_3590 poster thumb_475x350 (2)")
Targeted Detection of Ovarian Cancer Using Functionalized Iron Oxide Nanoparticles
Session: Tues, April 18th, 9:00am - 12:30pm EST
Poster: Section 3, #15; Abstract 3590
.png?width=475&height=350&name=AACR%202023_3586%20poster%20thumb_475x350%20(1).png "AACR 2023_3586 poster thumb_475x350 (1)")
In Vivo Targeted Detection and Imaging of Ovarian Cancer by SPMR and MRI Using Anti-Folate Receptor Functionalized Iron Oxide Nanoparticles
Session: Tues, April 18th, 9:00am - 12:30pm EST
Poster: Section 3, #11; Abstract 3586
Download our AACR 2023 Posters
You'll have immediate access to download.